Tearsheet

Veeva Systems (VEEV)

Market Price (11/8/2025): $295.0 | Market Cap: $48.2 Bil
Sector: Health Care | Industry: Health Care Technology

Veeva Systems (VEEV)

Market Price (11/8/2025): $295.0
Market Cap: $48.2 Bil
Sector: Health Care
Industry: Health Care Technology

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow

0	Cash is significant % of market cap Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -13%	Trading close to highs Dist 52W High is -3.7%, Dist 3Y High is -3.7%	Expensive valuation multiples P/EBITPrice/EBIT or Price/(Operating Income) ratio is 60x, P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 36x, P/EPrice/Earnings or Price/(Net Income) is 60x
1	Attractive operating margins Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is 27%	Weak multi-year price returns 2Y Excs Rtn is -2.9%	Yield minus risk free rate is negative ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -2.7%
2	Attractive cash flow generation CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 45%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 45%
3	Low stock price volatility Vol 12M is 36%

0	Cash is significant % of market cap Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -13%
1	Attractive operating margins Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is 27%
2	Attractive cash flow generation CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 45%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 45%
3	Low stock price volatility Vol 12M is 36%
4	Trading close to highs Dist 52W High is -3.7%, Dist 3Y High is -3.7%
5	Weak multi-year price returns 2Y Excs Rtn is -2.9%
6	Expensive valuation multiples P/EBITPrice/EBIT or Price/(Operating Income) ratio is 60x, P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 36x, P/EPrice/Earnings or Price/(Net Income) is 60x
7	Yield minus risk free rate is negative ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -2.7%

Market Valuation & Key Metrics

	11/8/25	2024	2023	2022
Share Price CYE	$295.00	$210.25	$192.52	$161.38
Market Cap CYE ($ Bil)	48.2	34.1	31.0	25.1
Total Debt ($ Bil)	0.1	0.1	0.1	0.1
Total Cash ($ Bil)	6.4	5.2	4.0	3.1
Enterprise Value ($ Bil)	41.9	34.2	31.1	25.2
Valuation Ratios
P/S TTM	16.2	12.4	13.1	11.6
P/EBIT TTM	60.3	49.2	72.0	54.6
P/E TTM	59.5	47.7	58.8	51.4
Sector Ratios
P/S TTM (Sector)	3.9	3.5	4.0	4.6
P/EBIT TTM (Sector)	-1.5	-1.3	-1.3	-1.3
P/E TTM (Sector)	-1.8	-1.5	-1.5	-1.3

	11/8/25	2024
Share Price CYE	$295.00	$210.25
Market Cap CYE ($ Bil)	48.2	34.1
Total Debt ($ Bil)	0.1	0.1
Total Cash ($ Bil)	6.4	5.2
Enterprise Value ($ Bil)	41.9	34.2
Valuation Ratios
P/S TTM	16.2	12.4
P/EBIT TTM	60.3	49.2
P/E TTM	59.5	47.7
Sector Ratios
P/S TTM (Sector)	3.9	3.5
P/EBIT TTM (Sector)	-1.5	-1.3
P/E TTM (Sector)	-1.8	-1.5

	VEEV	S&P 500
REVENUE GROWTH	GOOD
Rev LTM ($ Bil)	3.0
Rev Chg Q	16.7%	7.2%
Rev Chg LTM	15.3%	6.0%
Rev Chg 3Y Avg	14.1%	5.5%
PROFITABILITY	VERY GOOD
Op Inc LTM ($ Bil)	0.8
CFO LTM ($ Bil)	1.3
Net Inc LTM ($ Bil)	0.8
Op Mgn LTM	26.9%	18.8%
CFO/Rev LTM	45.5%	20.5%
Net Inc Mgn	27.3%	13.0%
VALUATION	VERY HIGH
P/S	16.2	3.2
P/CFO	35.7	15.2
P/FCF	35.7	20.0
P/E	59.5	23.6
STABILITY	VERY GOOD
Debt/Equity	0.00	0.21
Cash/Assets	0.80	0.07

AI Generated Analysis | Feedback

null

VEEV Stock

Return (1M):

Factor Drivers of Stock Movement

The 4.5% change in VEEV stock from 8/8/2025 to 11/7/2025 was primarily driven by a 4.0% change in the company's Total Revenues ($ Mil).

	8082025	11072025	Change
Stock Price ($)	282.13	294.86	4.51%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	2855.32	2968.22	3.95%
Net Income Margin (%)	27.34%	27.29%	-0.20%
P/E Multiple	58.82	59.52	1.20%
Shares Outstanding (Mil)	162.75	163.50	-0.46%
Cumulative Contribution			4.51%

LTM = Last Twelve Months as of date shown

The 24.4% change in VEEV stock from 5/9/2025 to 11/7/2025 was primarily driven by a 10.4% change in the company's P/E Multiple.

	5092025	11072025	Change
Stock Price ($)	237.05	294.86	24.39%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	2746.62	2968.22	8.07%
Net Income Margin (%)	26.00%	27.29%	4.95%
P/E Multiple	53.91	59.52	10.42%
Shares Outstanding (Mil)	162.40	163.50	-0.68%
Cumulative Contribution			24.38%

LTM = Last Twelve Months as of date shown

The 32.0% change in VEEV stock from 11/7/2024 to 11/7/2025 was primarily driven by a 15.3% change in the company's Total Revenues ($ Mil).

	11072024	11072025	Change
Stock Price ($)	223.39	294.86	31.99%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	2573.65	2968.22	15.33%
Net Income Margin (%)	23.91%	27.29%	14.14%
P/E Multiple	58.71	59.52	1.38%
Shares Outstanding (Mil)	161.71	163.50	-1.11%
Cumulative Contribution			31.98%

LTM = Last Twelve Months as of date shown

The 69.8% change in VEEV stock from 11/8/2022 to 11/7/2025 was primarily driven by a 48.3% change in the company's Total Revenues ($ Mil).

	11082022	11072025	Change
Stock Price ($)	173.68	294.86	69.77%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	2000.93	2968.22	48.34%
Net Income Margin (%)	19.67%	27.29%	38.69%
P/E Multiple	68.36	59.52	-12.93%
Shares Outstanding (Mil)	154.95	163.50	-5.51%
Cumulative Contribution			69.26%

LTM = Last Twelve Months as of date shown

Why The Stock Moved

AI Generated Analysis | Feedback

I apologize, but I cannot fulfill this request. The time period you've specified (7/31/2025 to today, November 8, 2025) is in the future from my current knowledge cut-off. I do not have access to real-time future stock market data or news events that have not yet occurred. Therefore, I cannot analyze the reasons for Veeva Systems' stock movement during that future period.

Return vs. Risk

Price Returns Compared

	2020	2021	2022	2023	2024	2025	Total [1]
Returns
VEEV Return	94%	-6%	-37%	19%	9%	39%	107%
Peers Return	37%	-12%	-39%	11%	-17%	-8%	-37%
S&P 500 Return	16%	27%	-19%	24%	23%	14%	108%
Monthly Win Rates [3]
VEEV Win Rate	67%	58%	33%	50%	58%	60%
Peers Win Rate	40%	22%	18%	33%	18%	53%
S&P 500 Win Rate	58%	75%	42%	67%	75%	70%
Max Drawdowns [4]
VEEV Max Drawdown	-14%	-11%	-41%	-2%	-11%	-0%
Peers Max Drawdown	-7%	-23%	-41%	-16%	-31%	-16%
S&P 500 Max Drawdown	-31%	-1%	-25%	-1%	-2%	-15%

[1] Cumulative total returns since the beginning of 2020
[2] Peers: SDGR, TDOC, OMCL, CARL, HTFL. See VEEV Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 11/7/2025 (YTD)

How Low Can It Go

Unique Key	Event	VEEV	S&P 500
2022 Inflation Shock	2022 Inflation Shock
2022 Inflation Shock% Loss	% Loss	-55.7%	-25.4%
2022 Inflation Shock% Gain to Breakeven	% Gain to Breakeven	125.7%	34.1%
2022 Inflation ShockTime to Breakeven	Time to Breakeven	Not Fully Recovered days	464 days
2020 Covid Pandemic	2020 Covid Pandemic
2020 Covid Pandemic% Loss	% Loss	-26.7%	-33.9%
2020 Covid Pandemic% Gain to Breakeven	% Gain to Breakeven	36.4%	51.3%
2020 Covid PandemicTime to Breakeven	Time to Breakeven	29 days	148 days
2018 Correction	2018 Correction
2018 Correction% Loss	% Loss	-26.5%	-19.8%
2018 Correction% Gain to Breakeven	% Gain to Breakeven	36.1%	24.7%
2018 CorrectionTime to Breakeven	Time to Breakeven	32 days	120 days

Compare to SDGR, TDOC, OMCL, CARL, HTFL

In The Past

Veeva Systems's stock fell -55.7% during the 2022 Inflation Shock from a high on 8/5/2021. A -55.7% loss requires a 125.7% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Veeva Systems (VEEV)

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud, a suite of software, data, and analytics solutions, which include Veeva customer relationship management (CRM) and Veeva Medical CRM, Veeva CLM, Veeva CRM MyInsights, Veeva CLM, Veeva CRM Approved Email, Veeva CRM Engage, Veeva Align, Veeva CRM Events Management, Veeva Nitro, Veeva OpenData, Veeva Link, Veeva Network, Veeva Crossix, Veeva Data Cloud, and MyVeeva for Patients; and Veeva Vault, a cloud-based enterprise content and data management applications for managing commercial functions, including sales and marketing, and medical content and communications, as well as research and development functions, such as clinical, regulatory, quality, and safety. It also provides professional and support services in the areas of implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; technical consulting services related to data migration and systems integrations; training on its solutions; and ongoing managed services that include outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.

AI Generated Analysis | Feedback

null

AI Generated Analysis | Feedback

null

AI Generated Analysis | Feedback

null

AI Generated Analysis | Feedback

null

AI Generated Analysis | Feedback

null

AI Generated Analysis | Feedback

null

AI Generated Analysis | Feedback

null

AI Generated Analysis | Feedback

null

AI Generated Analysis | Feedback

null

Better Bets than Veeva Systems (VEEV)

	VEEV	Better Performance than VEEV
Metric	Value	Industry (Health Care Technology)
Rev Chg LTM	15.3%	TEM (72.6%), DOCS (20.2%), TALK (18.4%), WEAV (17.3%), SLP (20.0%)
Rev Chg 3Y Avg	14.1%	TEM (59.8%), DOCS (17.4%), PHR (22.6%), EVH (29.2%), TALK (22.1%)
Op Mgn LTM	26.9%	DOCS (39.7%)
CFO/Rev LTM	45.5%	DOCS (51.5%)
FCF/Rev LTM	45.5%	DOCS (50.2%)
Total Yield	1.7%	SOLV (12.2%), DOCS (2.5%), WAY (1.8%), GDRX (2.9%), HSTM (3.3%)

	VEEV	Better Performance than VEEV
Metric	Value	Sector (Health Care)
Rev Chg LTM	15.3%	LLY (36.8%), ISRG (22.2%), BSX (21.6%), MCK (17.2%), CI (20.9%)
Rev Chg 3Y Avg	14.1%	LLY (23.4%), ISRG (16.3%), BSX (15.6%), ALNY (51.4%), INSM (22.8%)
Op Mgn LTM	26.9%	LLY (43.0%), MRK (34.9%), ISRG (29.3%), GILD (37.4%), IDXX (31.3%)
CFO/Rev LTM	45.5%	UTHR (49.7%), RPRX (102.4%), DOCS (51.5%), HALO (49.2%), KRYS (54.4%)
FCF/Rev LTM	45.5%	RPRX (102.4%), DOCS (50.2%), HALO (48.5%), KRYS (51.6%), INVA (50.9%)
Total Yield	1.7%	LLY (2.3%), JNJ (8.3%), ABBV (3.6%), UNH (8.7%), ABT (8.2%)

	VEEV	Better Performance than VEEV
Metric	Value	All Other Sectors
Rev Chg LTM	15.3%	NVDA (71.6%), MSFT (15.6%), AVGO (28.0%), META (21.3%), NFLX (15.4%)
Rev Chg 3Y Avg	14.1%	NVDA (92.0%), AVGO (24.0%), META (17.3%), BRK-B (19.8%), PLTR (29.3%)
Op Mgn LTM	26.9%	NVDA (58.1%), AAPL (31.9%), MSFT (46.3%), GOOGL (32.2%), AVGO (39.0%)
CFO/Rev LTM	45.5%	NVDA (46.6%), MSFT (50.0%), META (56.8%), MA (56.1%), V (57.6%)
FCF/Rev LTM	45.5%	MA (52.5%), V (53.9%), PLTR (46.0%), BAC (57.3%), APP (50.6%)
Total Yield	1.7%	NVDA (1.9%), AAPL (2.9%), MSFT (3.5%), GOOGL (4.0%), AMZN (2.7%)

		Best Bets In Health Care Sector
	VEEV	RPRX	HALO	DOCS	CPRX	BMY	MEDP	PBH	MRK	NBIX	ISRG
What You Pay
P/E	59.5	21.8	13.4	40.3	12.1	15.7	38.3	14.6	11.3	35.4	72.7
P/EBIT	60.3	10.5	10.5	41.3	10.1	9.5	32.7	9.0	9.3	26.0	70.9
What You Get
Rev Chg Q	16.7%	7.9%	22.1%	23.2%	15.3%	2.8%	23.7%	-3.4%	3.7%	27.8%	22.9%
Rev Chg LTM	15.3%	3.7%	31.2%	20.2%	25.6%	1.3%	13.9%	-0.0%	1.7%	19.6%	22.2%
Rev Chg 3Y Avg	14.1%	1.5%	29.0%	17.4%	46.5%	1.0%	19.9%	0.1%	2.9%	24.6%	16.3%
FCF/Rev 3Y Avg	42.7%	115.2%	45.0%	42.7%	34.2%	29.0%	25.3%	21.7%	22.0%	21.1%	16.5%

[1] Choosing top 10 best bets from each sector quarterly is an alpha producing strategy vs sector benchmark
[2] Historical annualized return of 11%, alpha of 1.9%, and sharpe of 0.52

Latest Trefis Analyses

	Title	Topic	Date
0	DASHBOARDS
1	Veeva Systems Earnings Notes
2	How Low Can Veeva Systems Stock Really Go?	Return
3	VEEV At Price Support Zone, Right Time To Buy?	Actionable
4	Wait For A Dip To Buy Veeva Systems Stock	Buy or Fear
5	As VEEV Falls 7.2% in a Day, DOCS's Story Stands Out	Counter-Intuitive Comparisons
6	null
7	Better Bet Than VEEV Stock: Pay Less Than Veeva Systems To Get More From NVDA, LLY
8	Better Bet Than VEEV Stock: Pay Less Than Veeva Systems To Get More From LLY, BMRN
9	VEEV Dip Buy Analysis
10	Wait For A Dip To Buy Veeva Systems Stock	Buy or Fear
11	ARTICLES
12	VEEV Hits Key Support – Is This The Buying Opportunity?		August 30th, 2025
13	VEEV Dips 7.2% In One Day, Wait For A Dip To Buy The Stock		August 29th, 2025
14	VEEV’s 7.2% One Day Dip Begs The Question: Is DOCS Better Instead?		August 29th, 2025
15	VEEV Dropped 7.2% In A Day. Have You Fully Evaluated The Risk?		August 29th, 2025
16	Large Cap Stocks Trading At 52-Week High		August 27th, 2025

	Title
0	DASHBOARDS
1	Veeva Systems Earnings Notes
2	How Low Can Veeva Systems Stock Really Go?
3	VEEV At Price Support Zone, Right Time To Buy?
4	Wait For A Dip To Buy Veeva Systems Stock
5	As VEEV Falls 7.2% in a Day, DOCS's Story Stands Out
6	null
7	Better Bet Than VEEV Stock: Pay Less Than Veeva Systems To Get More From NVDA, LLY
8	Better Bet Than VEEV Stock: Pay Less Than Veeva Systems To Get More From LLY, BMRN
9	VEEV Dip Buy Analysis
10	Wait For A Dip To Buy Veeva Systems Stock
11	ARTICLES
12	VEEV Hits Key Support – Is This The Buying Opportunity?
13	VEEV Dips 7.2% In One Day, Wait For A Dip To Buy The Stock
14	VEEV’s 7.2% One Day Dip Begs The Question: Is DOCS Better Instead?
15	VEEV Dropped 7.2% In A Day. Have You Fully Evaluated The Risk?
16	Large Cap Stocks Trading At 52-Week High

Trade Ideas

Select past ideas related to VEEV. For more, see Trefis Trade Ideas.

Unique Key	Date	Ticker	Company	Category	Trade Strategy	6M Fwd Rtn	12M Fwd Rtn	12M Max DD
GDRX_10312025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG	10312025	GDRX	GoodRx	Dip Buy	DB \| FCF Yield \| Low D/EDip Buy with High Free Cash Flow Yield Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap	-7.7%	-7.7%	-7.7%
DXCM_10312025_Monopoly_xInd_xCD_Getting_Cheaper	10312025	DXCM	DexCom	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	-5.5%	-5.5%	-5.5%
ACHC_10242025_Dip_Buyer_ValueBuy	10242025	ACHC	Acadia Healthcare	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	-16.6%	-16.6%	-16.6%
PBH_10102025_Dip_Buyer_ValueBuy	10102025	PBH	Prestige Consumer Healthcare	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	-1.7%	-1.7%	-1.9%
REGN_10032025_Dip_Buyer_ValueBuy	10032025	REGN	Regeneron Pharmaceuticals	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	9.6%	9.6%	-7.0%
VEEV_12312022_Monopoly_xInd_xCD_Getting_Cheaper	12312022	VEEV	Veeva Systems	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	22.5%	19.3%	-1.9%
VEEV_6302022_Monopoly_xInd_xCD_Getting_Cheaper	06302022	VEEV	Veeva Systems	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	-17.6%	-0.2%	-23.7%
VEEV_12312021_Monopoly_xInd_xCD_Getting_Cheaper	12312021	VEEV	Veeva Systems	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	-20.1%	-36.8%	-40.9%

Unique Key	Date	Ticker	Company	Category	Trade Strategy	6M Fwd Rtn	12M Fwd Rtn	12M Max DD
GDRX_10312025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG	10312025	GDRX	GoodRx	Dip Buy	DB \| FCF Yield \| Low D/EDip Buy with High Free Cash Flow Yield Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap	-7.7%	-7.7%	-7.7%
DXCM_10312025_Monopoly_xInd_xCD_Getting_Cheaper	10312025	DXCM	DexCom	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	-5.5%	-5.5%	-5.5%
ACHC_10242025_Dip_Buyer_ValueBuy	10242025	ACHC	Acadia Healthcare	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	-16.6%	-16.6%	-16.6%
PBH_10102025_Dip_Buyer_ValueBuy	10102025	PBH	Prestige Consumer Healthcare	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	-1.7%	-1.7%	-1.9%
REGN_10032025_Dip_Buyer_ValueBuy	10032025	REGN	Regeneron Pharmaceuticals	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	9.6%	9.6%	-7.0%
VEEV_12312022_Monopoly_xInd_xCD_Getting_Cheaper	12312022	VEEV	Veeva Systems	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	22.5%	19.3%	-1.9%
VEEV_6302022_Monopoly_xInd_xCD_Getting_Cheaper	06302022	VEEV	Veeva Systems	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	-17.6%	-0.2%	-23.7%
VEEV_12312021_Monopoly_xInd_xCD_Getting_Cheaper	12312021	VEEV	Veeva Systems	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	-20.1%	-36.8%	-40.9%

Recent Active Movers

1 Day Top Gainers

Ticker	Company	Mkt Cap (B)	1D Rtn	YTD Rtn
ORGO	Organogenesis	0.7	44.7%	75.9%
GMED	Globus Medical	11.3	35.9%	1.4%
KODK	Eastman Kodak	0.6	33.2%	18.6%
GCT	GigaCloud Technology	1.3	30.0%	78.8%
FROG	JFrog	6.9	27.0%	104.0%
PGNY	Progyny	1.9	24.2%	29.7%
TNDM	Tandem Diabetes Care	1.1	22.0%	-54.9%
OS	OneStream	4.1	19.2%	-20.3%
FLGT	Fulgent Genetics	0.8	18.2%	42.7%
UAMY	United States Antimony	1.0	17.8%	370.1%

1 Day Top Losers

Ticker	Company	Mkt Cap (B)	1D Rtn	YTD Rtn
AIRS	AirSculpt Technologies	0.4	-41.7%	17.9%
FOXF	Fox Factory	0.7	-25.5%	-45.9%
ASTH	Astrana Health	1.3	-23.5%	-19.0%
CERT	Certara	1.4	-23.1%	-18.6%
NTLA	Intellia Therapeutics	1.0	-22.7%	-18.4%
DNA	Ginkgo Bioworks	0.5	-20.8%	-8.9%
SIGA	SIGA Technologies	0.5	-20.0%	20.2%
UI	Ubiquiti	37.0	-19.4%	85.3%
EVCM	EverCommerce	1.7	-19.3%	-15.1%
PSIX	Power Solutions International	1.5	-19.1%	120.8%

1 Week Top Gainers

Ticker	Company	Mkt Cap (B)	1W Rtn	YTD Rtn
TERN	Terns Pharmaceuticals	1.7	123.6%	233.4%
GDEN	Golden Entertainment	0.8	44.7%	-4.9%
FSLY	Fastly	1.7	39.4%	22.5%
GMED	Globus Medical	11.3	38.9%	1.4%
CSIQ	Canadian Solar	1.9	37.1%	156.0%
HAE	Haemonetics	3.3	36.7%	-12.4%
ESTA	Establishment Labs	1.9	35.6%	41.1%
APPN	Appian	3.0	34.6%	22.2%
XMTR	Xometry	3.3	33.1%	51.9%
ORGO	Organogenesis	0.7	32.5%	75.9%

1 Week Top Losers

Ticker	Company	Mkt Cap (B)	1W Rtn	YTD Rtn
QURE	uniQure	1.5	-58.9%	57.4%
ASPN	Aspen Aerogels	0.3	-52.6%	-67.5%
BHVN	Biohaven	0.8	-52.0%	-77.9%
DD	DuPont de Nemours	16.7	-51.3%	-46.9%
SOC	Sable Offshore	0.5	-48.9%	-76.7%
BLZE	Backblaze	0.3	-43.7%	-3.7%
CCOI	Cogent Communications	1.1	-43.1%	-67.5%
NVTS	Navitas Semiconductor	1.6	-41.8%	119.6%
AIRS	AirSculpt Technologies	0.4	-41.2%	17.9%
ACVA	ACV Auctions	0.9	-40.5%	-75.0%

1 Month Top Gainers

Ticker	Company	Mkt Cap (B)	1M Rtn	YTD Rtn
PRAX	Praxis Precision Medicines	3.6	207.2%	118.6%
INBX	Inhibrx Biosciences	1.2	130.5%	424.0%
VTYX	Ventyx Biosciences	0.6	127.2%	300.5%
TERN	Terns Pharmaceuticals	1.7	117.3%	233.4%
PUMP	ProPetro	1.1	95.6%	15.1%
SNDK	SanDisk	34.7	84.7%
REPL	Replimune	0.8	79.5%	-31.4%
CSIQ	Canadian Solar	1.9	78.3%	156.0%
VICR	Vicor	3.9	66.2%	80.9%
ESTA	Establishment Labs	1.9	62.0%	41.1%

1 Month Top Losers

Ticker	Company	Mkt Cap (B)	1M Rtn	YTD Rtn
SOC	Sable Offshore	0.5	-72.8%	-76.7%
NTLA	Intellia Therapeutics	1.0	-62.6%	-18.4%
QURE	uniQure	1.5	-56.3%	57.4%
FMC	FMC	1.8	-53.2%	-69.9%
BHVN	Biohaven	0.8	-52.1%	-77.9%
ASPN	Aspen Aerogels	0.3	-51.4%	-67.5%
LRN	Stride	3.1	-50.3%	-30.7%
FI	Fiserv	35.1	-49.4%	-69.0%
WOLF	Wolfspeed	2.8	-49.3%
ELF	e.l.f. Beauty	4.2	-49.1%	-41.3%

Recent Active Movers

1 Day Top Gainers

Ticker	Company	Mkt Cap (B)	1D Rtn	YTD Rtn
ORGO	Organogenesis	0.7	44.7%	75.9%
GMED	Globus Medical	11.3	35.9%	1.4%
KODK	Eastman Kodak	0.6	33.2%	18.6%
GCT	GigaCloud Technology	1.3	30.0%	78.8%
FROG	JFrog	6.9	27.0%	104.0%
PGNY	Progyny	1.9	24.2%	29.7%
TNDM	Tandem Diabetes Care	1.1	22.0%	-54.9%
OS	OneStream	4.1	19.2%	-20.3%
FLGT	Fulgent Genetics	0.8	18.2%	42.7%
UAMY	United States Antimony	1.0	17.8%	370.1%

1 Day Top Losers

Ticker	Company	Mkt Cap (B)	1D Rtn	YTD Rtn
AIRS	AirSculpt Technologies	0.4	-41.7%	17.9%
FOXF	Fox Factory	0.7	-25.5%	-45.9%
ASTH	Astrana Health	1.3	-23.5%	-19.0%
CERT	Certara	1.4	-23.1%	-18.6%
NTLA	Intellia Therapeutics	1.0	-22.7%	-18.4%
DNA	Ginkgo Bioworks	0.5	-20.8%	-8.9%
SIGA	SIGA Technologies	0.5	-20.0%	20.2%
UI	Ubiquiti	37.0	-19.4%	85.3%
EVCM	EverCommerce	1.7	-19.3%	-15.1%
PSIX	Power Solutions International	1.5	-19.1%	120.8%

1 Week Top Gainers

Ticker	Company	Mkt Cap (B)	1W Rtn	YTD Rtn
TERN	Terns Pharmaceuticals	1.7	123.6%	233.4%
GDEN	Golden Entertainment	0.8	44.7%	-4.9%
FSLY	Fastly	1.7	39.4%	22.5%
GMED	Globus Medical	11.3	38.9%	1.4%
CSIQ	Canadian Solar	1.9	37.1%	156.0%
HAE	Haemonetics	3.3	36.7%	-12.4%
ESTA	Establishment Labs	1.9	35.6%	41.1%
APPN	Appian	3.0	34.6%	22.2%
XMTR	Xometry	3.3	33.1%	51.9%
ORGO	Organogenesis	0.7	32.5%	75.9%

1 Week Top Losers

Ticker	Company	Mkt Cap (B)	1W Rtn	YTD Rtn
QURE	uniQure	1.5	-58.9%	57.4%
ASPN	Aspen Aerogels	0.3	-52.6%	-67.5%
BHVN	Biohaven	0.8	-52.0%	-77.9%
DD	DuPont de Nemours	16.7	-51.3%	-46.9%
SOC	Sable Offshore	0.5	-48.9%	-76.7%
BLZE	Backblaze	0.3	-43.7%	-3.7%
CCOI	Cogent Communications	1.1	-43.1%	-67.5%
NVTS	Navitas Semiconductor	1.6	-41.8%	119.6%
AIRS	AirSculpt Technologies	0.4	-41.2%	17.9%
ACVA	ACV Auctions	0.9	-40.5%	-75.0%

Peer Comparisons for Veeva Systems

Financials

	VEEV	SDGR	TDOC	OMCL	CARL	HTFL	Median
Name	Veeva Sy.	Schrodin.	Teladoc .	Omnicell	Carlsmed	HeartFlow
Mkt Price	294.86	17.78	7.53	35.68	13.66	32.56	25.17
Mkt Cap	48.2	1.3	1.3	1.6	-	-	1.5
Rev LTM	2,968	257	2,528	1,178	33	139	717
Op Inc LTM	799	-170	-179	17	-24	-61	-43
FCF LTM	1,349	-3	140	94	-30	-90	45
FCF 3Y Avg	1,108	-104	153	126	-	-	139
CFO LTM	1,349	-1	293	153	-29	-85	76
CFO 3Y Avg	1,108	-96	305	183	-	-	244

Growth & Margins

	VEEV	SDGR	TDOC	OMCL	CARL	HTFL	Median
Name	Veeva Sy.	Schrodin.	Teladoc .	Omnicell	Carlsmed	HeartFlow
Rev Chg LTM	15.3%	32.9%	-2.4%	10.7%	-	-	13.0%
Rev Chg 3Y Avg	14.1%	15.7%	3.0%	-3.0%	-	-	8.5%
Rev Chg Q	16.7%	53.9%	-2.2%	10.0%	-	-	13.3%
QoQ Delta Rev Chg LTM	4.0%	8.0%	-0.6%	2.5%	-	-	3.2%
Op Mgn LTM	26.9%	-66.3%	-7.1%	1.5%	-71.4%	-44.4%	-25.7%
Op Mgn 3Y Avg	22.5%	-89.2%	-7.6%	-2.0%	-	-	-4.8%
QoQ Delta Op Mgn LTM	-0.0%	14.8%	0.2%	0.1%	-	-	0.1%
CFO/Rev LTM	45.5%	-0.4%	11.6%	13.0%	-86.4%	-61.5%	5.6%
CFO/Rev 3Y Avg	42.7%	-49.1%	11.9%	16.0%	-	-	13.9%
FCF/Rev LTM	45.5%	-1.3%	5.5%	8.0%	-88.9%	-65.0%	2.1%
FCF/Rev 3Y Avg	42.7%	-53.0%	6.0%	11.0%	-	-	8.5%

Valuation

	VEEV	SDGR	TDOC	OMCL	CARL	HTFL	Median
Name	Veeva Sy.	Schrodin.	Teladoc .	Omnicell	Carlsmed	HeartFlow
Mkt Cap	48.2	1.3	1.3	1.6	-	-	1.5
P/S	16.2	5.1	0.5	1.4	-	-	3.2
P/EBIT	60.3	-7.7	-5.8	94.8	-	-	27.2
P/E	59.5	-7.4	-6.0	81.6	-	-	26.8
P/CFO	35.7	-1,167.6	4.6	10.6	-	-	7.6
Total Yield	1.7%	-13.4%	-16.8%	1.2%	-	-	-6.1%
Dividend Yield	0.0%	0.0%	0.0%	0.0%	-	-	0.0%
FCF Yield 3Y Avg	3.1%	-6.6%	9.0%	6.9%	-	-	5.0%
D/E	0.0	0.1	0.8	0.1	-	-	0.1
Net D/E	-0.1	-0.2	0.2	0.0	-	-	-0.1

Returns

	VEEV	SDGR	TDOC	OMCL	CARL	HTFL	Median
Name	Veeva Sy.	Schrodin.	Teladoc .	Omnicell	Carlsmed	HeartFlow
1M Rtn	-2.3%	-14.2%	-17.2%	13.4%	-1.2%	-8.9%	-5.6%
3M Rtn	4.5%	-7.4%	8.2%	15.7%	7.4%	13.3%	7.8%
6M Rtn	24.4%	-25.6%	5.9%	38.4%	-	-	15.1%
12M Rtn	32.0%	-5.3%	-20.8%	-32.0%	-	-	-13.1%
3Y Rtn	69.8%	-14.0%	-72.4%	-26.2%	-	-	-20.1%
1M Excs Rtn	-1.1%	-13.8%	-14.8%	14.7%	0.0%	-0.9%	-1.0%
3M Excs Rtn	0.9%	-10.1%	5.5%	10.2%	-1.0%	3.0%	1.9%
6M Excs Rtn	5.5%	-44.5%	-13.0%	19.5%	-	-	-3.7%
12M Excs Rtn	22.3%	-17.0%	-34.1%	-44.7%	-	-	-25.5%
3Y Excs Rtn	7.1%	-106.4%	-152.1%	-107.6%	-	-	-107.0%

Financials

Annual
Quarterly

$ Mil \| FY: 1/31	LTM	2025	2024	2023	2022	2021	2020
Period End	7/31/2025	1/31/2025	1/31/2024	1/31/2023	1/31/2022	1/31/2021	1/31/2020
Filing Date	8/29/2025	3/24/2025	3/25/2024	3/30/2023	3/30/2022	3/30/2021	3/30/2020
Key Financials
Total Revenue	2,968	2,747	2,364	2,155	1,851	1,465	1,104
EBITDA	839	731	462	488	533	407	306
Operating Income	799	691	429	459	505	378	286
Net Income	810	714	526	488	427	380	301
EPS	4.98	4.41	3.27	3.14	2.79	2.52	2.04
Growth Rates
Total Revenue Growth	15.3%	16.2%	9.7%	16.4%	26.3%	32.7%	28.1%
EBITDA Growth	34.9%	58.2%	-5.4%	-8.4%	30.9%	33.1%	29.2%
Operating Income Growth	36.6%	61.0%	-6.5%	-9.2%	33.8%	32.0%	28.4%
Net Income Growth	31.6%	35.8%	7.8%	14.1%	12.5%	26.2%	31.0%
Margins
EBITDA Margin	28.3%	26.6%	19.5%	22.7%	28.8%	27.8%	27.7%
Operating Income Margin	26.9%	25.2%	18.2%	21.3%	27.3%	25.8%	25.9%
Net Income Margin	27.3%	26.0%	22.2%	22.6%	23.1%	25.9%	27.3%
Cash & Debt
Total Cash	6,404	5,150	4,028	3,103	2,376	1,664	1,087
Total Debt	85	76	56	61	55	63	55
Net Debt / (Cash)	-6,318	-5,074	-3,972	-3,042	-2,322	-1,601	-1,032
Cash Flows
Net Cash from Operations	1,349	1,090	911	780	764	551	437
Free Cash from Operations	1,349	1,090	911	780	764	551	433
Returns to Shareholders
Dividends	0	-0	-0	-0	-0	-0	-0
Share Repurchases	-0	-0	-0	-0	-0	-0	-0

$ Mil \| FY: 1/31	2026Q2	2026Q1	2025Q4	2025Q3	2025Q2	2025Q1	2024Q4	2024Q3	2024Q2	2024Q1	2023Q4	2023Q3
Period End	7/31/2025	4/30/2025	1/31/2025	10/31/2024	7/31/2024	4/30/2024	1/31/2024	10/31/2023	7/31/2023	4/30/2023	1/31/2023	10/31/2022
Filing Date	8/29/2025	6/2/2025	3/24/2025	12/9/2024	9/4/2024	6/4/2024	3/25/2024	12/7/2023	9/1/2023	6/2/2023	3/30/2023	12/7/2022
Key Financials Quarterly
Total Revenue	789	759	721	699	676	650	631	617	590	526	563	552
Ebitda	206	244	198	191	178	164	144	137	112	69	117	129
Operating Income	196	234	188	181	166	155	135	128	104	62	109	121
Net Income	200	228	196	186	171	162	147	135	112	132	189	108
EPS	1.23	1.40	1.20	1.15	1.06	1.00	0.92	0.84	0.70	0.82	1.20	0.70
Key Financials TTM
Total Revenue TTM	2,968	2,855	2,747	2,656	2,574	2,488	2,364	2,296	2,232	2,176	2,155	2,077
Ebitda TTM	839	811	731	676	622	557	462	435	426	423	488	498
Operating Income TTM	799	770	691	638	585	523	429	403	396	393	459	470
Net Income TTM	810	781	714	666	615	556	526	567	540	519	488	396
Growth Rates Quarterly
Total Revenue Growth	16.7%	16.7%	14.3%	13.4%	14.6%	23.6%	11.9%	11.6%	10.5%	4.2%	16.0%	16.0%
EBITDA Growth	16.1%	48.8%	37.8%	39.8%	58.3%	136.9%	23.4%	6.4%	3.5%	-48.7%	-8.0%	-7.9%
Operating Income Growth	17.7%	50.6%	39.3%	41.1%	60.0%	152.2%	24.2%	5.8%	2.9%	-51.8%	-9.0%	-8.5%
Net Income Growth	17.1%	41.2%	32.7%	37.5%	53.2%	22.9%	-21.8%	24.6%	23.2%	31.4%	94.2%	2.4%
Margins Quarterly
EBITDA Margin	26.1%	32.1%	27.5%	27.4%	26.3%	25.2%	22.8%	22.2%	19.0%	13.1%	20.7%	23.3%
Operating Income Margin	24.8%	30.8%	26.1%	25.9%	24.6%	23.9%	21.4%	20.8%	17.6%	11.7%	19.3%	22.0%
Net Income Margin	25.4%	30.1%	27.1%	26.6%	25.3%	24.9%	23.4%	21.9%	18.9%	25.0%	33.5%	19.6%
Cash & Debt
Total Cash	6,404	6,068	5,150	5,063	4,885	4,765	4,028	3,942	3,869	3,615	3,103	3,023
Total Debt	85	77	76	72	54	56	56	58	59	58	61	62
Net Debt / (Cash)	-6,318	-5,991	-5,074	-4,991	-4,831	-4,709	-3,972	-3,885	-3,810	-3,557	-3,042	-2,961
Cash Flows Quarterly
FCF from Operations	238	877	70	164	93	764	58	83	265	506	63	143
Cash Flows TTM
FCF from Operations TTM	1,349	1,204	1,090	1,078	997	1,169	911	917	977	805	780	771
Returns to Shareholders Quarterly
Dividends	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Return on Invested Capital (ROIC) Quarterly
ROIC	-	-	-	-	-	-	-	-	-	-	-	-
Return on Invested Capital (ROIC) TTM
ROIC TTM	-	-	-	-	-	-	-	-	-	-	-	-

Segment Financials

Revenue by Segment

$ Mil	2025	2024	2023	2022	2021
Subscription services	1,902	1,733	1,484	1,179	896
Professional services	462	422	367	286	208
Total	2,364	2,155	1,851	1,465	1,104

Price Behavior

Price Behavior

Market Price	$294.86
Market Cap ($ Bil)	48.2
First Trading Date	10/16/2013
Distance from 52W High	-3.7%
	50 Days	200 Days
DMA Price	$286.36	$261.00
DMA Trend	up	up
Distance from DMA	3.0%	13.0%
	3M	1YR
Volatility	28.6%	35.9%
Downside Capture	41.61	80.99
Upside Capture	53.65	98.71
Correlation (SPY)	27.2%	35.8%

VEEV Betas & Captures as of 10/31/2025

	1M	2M	3M	6M	1Y	3Y
Beta	0.60	0.69	0.76	0.81	0.66	0.89
Up Beta	0.25	0.12	0.92	0.48	0.43	0.74
Down Beta	1.53	1.28	1.11	1.08	0.65	0.74
Up Capture	-11%	69%	46%	92%	98%	116%
Bmk +ve Days	14	27	37	74	145	425
Stock +ve Days	12	24	34	65	126	369
Down Capture	23%	26%	60%	80%	88%	102%
Bmk -ve Days	9	17	28	53	106	327
Stock -ve Days	11	20	31	61	124	382

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

1Y 5Y 10Y

Based On 1-Year Data

		Comparison of VEEV With Other Asset Classes (Last 1Y)
	VEEV	Sector ETF	Equity	Gold	Commodities	Real Estate	Bitcoin
Annualized Return	38.7%	0.9%	18.9%	45.7%	0.7%	-1.3%	49.7%
Annualized Volatility	35.8%	17.0%	19.6%	19.9%	16.1%	18.0%	37.2%
Sharpe Ratio	0.97	-0.11	0.76	1.78	-0.14	-0.22	0.85
Correlation With Other Assets		35.3%	35.9%	-2.4%	-1.5%	27.6%	6.9%

ETFs used for asset classes: Sector ETF = XLV, Equity = SPY, Gold = GLD, Commodities = DBC, Real Estate = VNQ, and Bitcoin = BTCUSD
Smart multi-asset allocation framework can stack odds in your favor. Learn How

Based On 5-Year Data

		Comparison of VEEV With Other Asset Classes (Last 5Y)
	VEEV	Sector ETF	Equity	Gold	Commodities	Real Estate	Bitcoin
Annualized Return	1.8%	9.2%	17.1%	15.9%	13.8%	7.2%	49.2%
Annualized Volatility	37.9%	14.5%	17.1%	15.6%	18.9%	19.1%	49.3%
Sharpe Ratio	0.15	0.45	0.81	0.82	0.61	0.29	0.76
Correlation With Other Assets		36.1%	47.2%	11.5%	6.7%	35.4%	22.1%

Based On 10-Year Data

		Comparison of VEEV With Other Asset Classes (Last 10Y)
	VEEV	Sector ETF	Equity	Gold	Commodities	Real Estate	Bitcoin
Annualized Return	27.8%	9.2%	14.3%	12.9%	5.1%	5.3%	77.5%
Annualized Volatility	37.8%	16.7%	18.0%	14.7%	17.7%	20.9%	56.2%
Sharpe Ratio	0.77	0.45	0.69	0.72	0.22	0.23	0.95
Correlation With Other Assets		44.6%	50.8%	6.6%	13.1%	34.2%	14.7%

Short Interest

Short Interest: As Of Date	10152025
Short Interest: Shares Quantity	4,503,453
Short Interest: % Change Since 9302025	-15.5%
Average Daily Volume	1,283,635
Days-to-Cover Short Interest	3.51
Basic Shares Quantity	163,496,000
Short % of Basic Shares	2.8%

Returns Analyses

	Title
0	How Low Can Veeva Systems Stock Really Go?
1	Veeva Systems Stock Return Comparison
2	[10/7/2021] Veeva Systems (VEEV) Stock Price Forecast: AI Forecasts VEEV Stock Price To Be Around $295 In A Month (Up 2.6%)
3	Veeva Systems (VEEV) Stock Return: AI Predicts VEEV Average and Excess Return After a Fall or Rise

Earnings Returns History

Expand for More

	Forward Returns
Earnings Date	1D Returns	5D Returns	21D Returns
8/27/2025	-7.2%	-8.0%	-1.1%
5/28/2025	19.0%	20.9%	20.9%
3/5/2025	7.4%	6.1%	0.7%
11/8/2024	5.2%	2.8%	10.1%
8/28/2024	8.9%	8.0%	5.8%
5/30/2024	-10.3%	-4.7%	-6.4%
2/29/2024	-1.6%	2.1%	2.2%
11/9/2023	-14.2%	-8.9%	-11.0%
...
SUMMARY STATS
# Positive	12	14	13
# Negative	12	10	11
Median Positive	7.9%	5.1%	8.5%
Median Negative	-7.8%	-9.2%	-9.1%
Max Positive	19.7%	20.9%	21.6%
Max Negative	-16.2%	-18.2%	-17.3%

	Forward Returns
8/27/2025	-7.2%	-8.0%	-1.1%
5/28/2025	19.0%	20.9%	20.9%
3/5/2025	7.4%	6.1%	0.7%
11/8/2024	5.2%	2.8%	10.1%
8/28/2024	8.9%	8.0%	5.8%
5/30/2024	-10.3%	-4.7%	-6.4%
2/29/2024	-1.6%	2.1%	2.2%
11/9/2023	-14.2%	-8.9%	-11.0%
8/30/2023	8.4%	15.3%	5.6%
5/31/2023	19.7%	14.0%	19.3%
3/1/2023	4.5%	3.9%	7.8%
12/1/2022	-8.6%	-9.6%	-16.6%
8/31/2022	-14.0%	-12.4%	-17.3%
6/1/2022	14.7%	14.1%	21.6%
3/2/2022	-16.2%	-18.2%	-7.9%
12/1/2021	-3.6%	0.3%	-6.1%
9/1/2021	-5.4%	-8.3%	-13.9%
5/27/2021	10.1%	8.9%	20.4%
3/2/2021	-8.3%	-12.7%	-9.1%
12/1/2020	-4.2%	-5.2%	-4.2%
8/27/2020	1.4%	4.1%	4.3%
5/28/2020	7.2%	1.0%	15.0%
3/3/2020	1.9%	3.4%	8.5%
11/26/2019	-3.7%	-9.6%	-11.7%
SUMMARY STATS
# Positive	12	14	13
# Negative	12	10	11
Median Positive	7.9%	5.1%	8.5%
Median Negative	-7.8%	-9.2%	-9.1%
Max Positive	19.7%	20.9%	21.6%
Max Negative	-16.2%	-18.2%	-17.3%

SEC Filings

Expand for More

Report Date	Filing Date	Filing
7312025	8292025	10-Q 7/31/2025
4302025	6022025	10-Q 4/30/2025
1312025	3242025	10-K 1/31/2025
10312024	12092024	10-Q 10/31/2024
7312024	9042024	10-Q 7/31/2024
4302024	6042024	10-Q 4/30/2024
1312024	3252024	10-K 1/31/2024
10312023	12072023	10-Q 10/31/2023
7312023	9012023	10-Q 7/31/2023
4302023	6022023	10-Q 4/30/2023
1312023	3302023	10-K 1/31/2023
10312022	12072022	10-Q 10/31/2022
7312022	9022022	10-Q 7/31/2022
4302022	6032022	10-Q 4/30/2022
1312022	3302022	10-K 1/31/2022
10312021	12032021	10-Q 10/31/2021

Insider Activity

Expand for More

Industry Resources

Health Care Resources

U.S. National Library of Medicine

Health Data Management

FDA Tracker

External Quote Links

0	Y Finance	Barrons
1	TradingView	Morningstar
2	SeekingAlpha	ValueLine
3	Motley Fool	Robinhood
4	CNBC	Etrade
5	MarketWatch	Unusual Whales
6	YCharts	Perplexity Finance
7	FinViz

Prefer one of these to Trefis? Tell us why.

Veeva Systems (VEEV)

Market Price (11/8/2025): $295.0 | Market Cap: $48.2 BilSector: Health Care | Industry: Health Care Technology

Veeva Systems (VEEV)

Market Price (11/8/2025): $295.0Market Cap: $48.2 BilSector: Health CareIndustry: Health Care Technology

Market Valuation & Key Metrics

VEEV Stock

Return vs. Risk

Price Returns Compared

How Low Can It Go

In The Past

Preserve Wealth

Asset Allocation

About Veeva Systems (VEEV)

Interactive Breakdown

Better Bets than Veeva Systems (VEEV)

Latest Trefis Analyses

Trade Ideas

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

1 Month Top Gainers

1 Month Top Losers

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Veeva Systems

Financials

Growth & Margins

Valuation

Returns

Comparison Analyses

FDIC Bank Data

Bank Capital

Bank Deposits

Bank Assets

Bank Loans

Financials

Segment Financials

Price Behavior

Based On 1-Year Data

Based On 5-Year Data

Based On 10-Year Data

Short Interest

Returns Analyses

Earnings Returns History

SEC Filings

Insider Activity

Industry Resources

External Quote Links

Market Price (11/8/2025): $295.0 | Market Cap: $48.2 Bil
Sector: Health Care | Industry: Health Care Technology

Market Price (11/8/2025): $295.0
Market Cap: $48.2 Bil
Sector: Health Care
Industry: Health Care Technology